George Church-en­dorsed start­up seeks 'al­ter­na­tives'; DOJ clos­es On­pat­tro mar­ket­ing in­ves­ti­ga­tion

NeuBase is putting up the “For Sale” sign, rough­ly 10 months af­ter lay­ing off most of its em­ploy­ees.

The Di­et­rich Stephan biotech, whose gene edit­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.